Correlation Between Palisade Bio and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Palisade Bio and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palisade Bio and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palisade Bio and Immix Biopharma, you can compare the effects of market volatilities on Palisade Bio and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palisade Bio with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palisade Bio and Immix Biopharma.
Diversification Opportunities for Palisade Bio and Immix Biopharma
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Palisade and Immix is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Palisade Bio and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Palisade Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palisade Bio are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Palisade Bio i.e., Palisade Bio and Immix Biopharma go up and down completely randomly.
Pair Corralation between Palisade Bio and Immix Biopharma
Given the investment horizon of 90 days Palisade Bio is expected to under-perform the Immix Biopharma. In addition to that, Palisade Bio is 1.27 times more volatile than Immix Biopharma. It trades about -0.25 of its total potential returns per unit of risk. Immix Biopharma is currently generating about 0.05 per unit of volatility. If you would invest 168.00 in Immix Biopharma on August 28, 2024 and sell it today you would earn a total of 4.00 from holding Immix Biopharma or generate 2.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Palisade Bio vs. Immix Biopharma
Performance |
| Timeline |
| Palisade Bio |
| Immix Biopharma |
Palisade Bio and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Palisade Bio and Immix Biopharma
The main advantage of trading using opposite Palisade Bio and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palisade Bio position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| Palisade Bio vs. Zura Bio Limited | Palisade Bio vs. Altamira Therapeutics | Palisade Bio vs. Immix Biopharma | Palisade Bio vs. Enveric Biosciences |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |